| DNA binding sites for the transcriptional activator/repressor YY1 RP Hyde-DeRuyscher, E Jennings, T Shenk Nucleic acids research 23 (21), 4457-4465, 1995 | 254 | 1995 |
| Detection of small-molecule enzyme inhibitors with peptides isolated from phage-displayed combinatorial peptide libraries R Hyde-DeRuyscher, LA Paige, DJ Christensen, N Hyde-DeRuyscher, ... Chemistry & biology 7 (1), 17-25, 2000 | 151 | 2000 |
| From peptides to drugs via phage display BK Kay, AV Kurakin, R Hyde-DeRuyscher Drug Discovery Today 3 (8), 370-378, 1998 | 126 | 1998 |
| Polyomavirus early-late switch is not regulated at the level of transcription initiation and is associated with changes in RNA processing. R Hyde-DeRuyscher, GG Carmichael Proceedings of the National Academy of Sciences 85 (23), 8993-8997, 1988 | 120 | 1988 |
| Expression and localization of myelin basic protein in oligodendrocytes and transfected fibroblasts E Barbarese, C Barry, CHJ Chou, DJ Goldstein, GA Nakos, ... Journal of neurochemistry 51 (6), 1737-1745, 1988 | 87 | 1988 |
| Identification of drug complementary combinatorial libraries DM Fowlkes, BK Kay, JA Frelinger, RP Hyde-Deruyscher US Patent 6,617,114, 2003 | 50 | 2003 |
| Polyomavirus late pre-mRNA processing: DNA replication-associated changes in leader exon multiplicity suggest a role for leader-to-leader splicing in the early-late switch RP Hyde-DeRuyscher, GG Carmichael Journal of virology 64 (12), 5823-5832, 1990 | 43 | 1990 |
| Improved bone morphogenetic protein-2 retention in an injectable collagen matrix using bifunctional peptides PT Hamilton, MS Jansen, S Ganesan, RE Benson, R Hyde-DeRuyscher, ... PLoS One 8 (8), e70715, 2013 | 42 | 2013 |
| Peptides as tools in drug discovery. H Grøn, R Hyde-DeRuyscher Current Opinion in Drug Discovery & Development 3 (5), 636-645, 2000 | 37 | 2000 |
| Phage Display in Biotechnology and Drug Discovery DJ Rodi, S Mandova, L Makowski Vectors 1, 41, 2005 | 14 | 2005 |
| IFBMs to promote the specific attachment of target analytes to the surface of orthopedic implants WF Beyer Jr, R Hyde-DeRuyscher, PT Hamilton, RE Benson US Patent 7,572,766, 2009 | 11 | 2009 |
| Mast cell stabilizers for treatment of hypercytokinemia and viral infection RP Hyde-Deruyscher, NH Hyde-DeRuyscher, EK Hyde-DeRuyscher US Patent 10,501,527, 2019 | 8 | 2019 |
| Mast cell stabilizers for treatment of hypercytokinemia and viral infection RP Hyde-Deruyscher, NH Hyde-DeRuyscher, EK Hyde-DeRuyscher US Patent 10,494,420, 2019 | 5 | 2019 |
| Mast cell stabilizers for treatment of hypercytokinemia and viral infection RP Hyde-Deruyscher, NH Hyde-DeRuyscher, EK Hyde-DeRuyscher US Patent 10,160,796, 2018 | 5 | 2018 |
| Mast cell stabilizers for treatment of chronic inflammatory conditions RP Hyde-Deruyscher US Patent 11,478,463, 2022 | 2 | 2022 |
| Mast cell stabilizers for treatment of fever RP Hyde-Deruyscher, NH Hyde-DeRuyscher, EK Hyde-DeRuyscher US Patent 11,072,648, 2021 | 2 | 2021 |
| Mast cell stabilizers for treatment of hypercytokinemia and viral infection RP Hyde-Deruyscher, NH Hyde-DeRuyscher, EK Hyde-DeRuyscher US Patent 10,787,502, 2020 | 2 | 2020 |
| IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants WF Beyer Jr, R Hyde-DeRuyscher, PT Hamilton, RE Benson US Patent 7,790,844, 2010 | 2 | 2010 |
| IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants WF Beyer Jr, R Hyde-DeRuyscher, PT Hamilton, RE Benson US Patent 7,812,119, 2010 | 1 | 2010 |
| IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants WF Beyer Jr, R Hyde-DeRuyscher, PT Hamilton, RE Benson US Patent 7,795,383, 2010 | 1 | 2010 |
